Magazine
2009 Annual Outsourcing Survey
Welcome to our 5th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type:
- Top 20 Pharma - 26.2%
- Small/Mid-Tier Pharma - 18.6%
- Generic Pharma - 9.5%
- Specialty Pharma - 9.0%
- Virtual Pharma - 8.6%
- Emerging Biopharma - 7.2%
- Top 10 Biopharma - 6.8%
- Other - 14.0%
Holding the Fort?
Last year, 16% of total respondents believed that they’d spend the same or less on outsourcing spending in the coming year; this year, that number ballooned to 62%. Anticipating that we’d see reduced outsourcing spending in the recession, we changed the “less than last year” response to “1-5% less," “6-10% less” and “10+% less.” Sadly, the 10+% less outsourcing spend group clocked in at 23% of total responses.
The no change in spending class grew from 6% to 25% in that span, but the number of respondents who said their spending would shrink rose from 10% to 37%. Last year, 23% of respondents reported they’d increase outsourcing spending by 10% or more; that number dropped to 16% this time around. A few years from now, we’ll look back on this and laugh. Trust me.
For an expanded, 28-page PDF of this year's Outsourcing Survey, including information on spending growth, preferred vendor strategies, sponsor attitudes, and outsourcing to Asia, just click here!
(Looking for the 2008 edition? Click here! How about the 2007 one? We've got you covered!)
--Gil Y. Roth
Editor
Contract Pharma
PS: Thanks to all of you who took the time to respond to this year’s Outsourcing Survey. The winner of our 16gb iPod Touch drawing is Pinar Cicalese of GlaxoSmithKline! Congratulations!
